Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Adult Brain Tumor Consortium
Baltimore, Maryland, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Henry Ford Cancer Institute¿downriver
Brownstown, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Henry Ford West Bloomfield Hospital
West Bloomfield, Michigan, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2015
- Primary completion
- 16 Feb 2017
- Completion
- 16 Feb 2017
- Last update posted
- 4 Apr 2019
- Registered enrollment
- 20
- Registry id
- NCT02395692
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.